Table 3. Site of recurrence according to mutational status.

	Bone	Liver	Brain	Pleuro-pericardial	Lung	Adrenal glands
Wild type (n=258)	57 (22%)	39 (15%)	26 (10%)	37 (14%)	89 (35%)	10 (4%)
EGFR (n=27)	0	8 (30%)	16 (59%)	2 (7%)	1 (4%)	0
KRAS G12C (n=91)	54 (59%)	1 (1%)	7 (8%)	9 (10%)	16 (18%)	4 (4%)
KRAS G12V (n=85)	0	4 (5%)	0	80 (94%)	1 (1%)	0
Other KRAS (n=20)	7 (35%)	4 (20%)	2 (10%)	0 (0%)	5 (25%)	2 (10%)
P-value	<0.0001	<0.0001	<0.0001	<0.0001	<0.0001	0.13

Abbreviations: EGFR=epidermal growth factor receptor; KRAS=V-Ki-ras2 Kirsten rat sarcoma viral oncogene homologue.

Data are given as n (%).